ANEB Insider Trading Activity and SEC Form 4 Filings
ANEB insider trading summary
No open-market insider purchases or sales of Anebulo Pharmaceuticals, Inc. (ANEB) have been reported on SEC Form 4 in the past 12 months.
Latest ANEB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 23, 2024 | Aron R. English | Director | Buy | $10.0M (10,101,010 @ $0.99) |
| Dec 23, 2024 | 22NW Fund, LP | 10% Owner | Buy | $10.0M (10,101,010 @ $0.99) |
| Dec 17, 2021 | Aron R. English | Director | Buy | $3K (400 @ $6.59) |
| Dec 17, 2021 | 22NW Fund, LP | Insider | Buy | $3K (400 @ $6.59) |
| Dec 14, 2021 | Aron R. English | Director | Buy | $2K (412 @ $5.89) |
| Dec 14, 2021 | 22NW Fund, LP | Insider | Buy | $2K (412 @ $5.89) |
| Dec 3, 2021 | Aron R. English | Director | Buy | $27K (4,500 @ $5.93) |
| Dec 3, 2021 | 22NW Fund, LP | Insider | Buy | $27K (4,500 @ $5.93) |
| Dec 2, 2021 | Aron R. English | Director | Buy | $73K (13,836 @ $5.30) |
| Dec 2, 2021 | 22NW Fund, LP | Insider | Buy | $73K (13,836 @ $5.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.